KASINGER JAMES R. bought CRSP
May 29, 2026 · Form 4 insider transaction
KASINGER JAMES R. bought 17,000 shares of CRISPR Therapeutics AG at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,000
Price
$0.00
Total value
N/A
InsiderKASINGER JAMES R.
RoleOfficer
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMay 29, 2026
Filing dateJune 2, 2026
Shares owned after17,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.; This restricted stock unit award was granted on May 29, 2026 with respect to 17,000 Common Shares, with 100% of the shares vesting on November 29, 2028.